Excerpt from Lymphogranuloma VenereumSynonyms, Key Words, and Related Terms: Chlamydia trachomatis, C trachomatis, STD, sexually transmitted chlamydial disease, sexually transmitted disease, chlamydia, LGV Please click here to view the full topic text: Lymphogranuloma VenereumBackgroundLymphogranuloma venereum (LGV) is a sexually transmitted chlamydial disease that should be a part of the differential diagnosis for any patient presenting with a genital ulcer and/or inguinal lymphadenopathy. Treatment involves the use of antibiotics to clear the infection and to prevent tertiary sequelae. The disease is an important emerging sexually transmitted disease among men who have sex with men. PathophysiologyChlamydia trachomatis, an obligate intracellular organism, is the causative agent, and serotypes L1, L2, and L3 have been associated with infection. While other serotypes of C trachomatis are limited to superficial infection of mucous membranes, serotypes L1, L2, and L3 are more invasive and virulent, tending to result in systemic disease. The organism travels through the lymphatics to multiply within macrophages in regional lymph nodes. Characterization of the rate of transmission or the reservoir of C trachomatis has not been defined clearly, although asymptomatic women are believed to be a source of infection. LGV occurs in 3 stages, the first of which has an incubation period of anywhere from 3 days to 6 weeks (10-14 d average) and is characterized by a painless genital papule, which usually disappears after a few days. The onset of the second stage occurs 2-6 weeks later and often manifests as unilateral inguinal lymphadenopathy. The third stage may occur years after the initial infection and is termed genitoanorectal syndrome. FrequencyUnited StatesOnly 113 cases were reported to the Centers for Disease Control and Prevention in 1997. The true incidence of the disease is believed to be 400-600 cases per year. InternationalLGV is most common in Southeast Asia, Africa, Central America, and the Caribbean. LGV accounts for 2-10% of genital ulcer disease in India and Africa. Mortality/MorbidityComplete cure is achieved by early recognition and appropriate antibiotic treatment. Progression to the third stage of the disease can result in serious and sometimes permanent sequelae such as genital deformity, fistulas, and rectal strictures. Death is rare but may be caused by complete bowel obstruction and perforation resulting from a rectal stricture. RaceAs a cause of rectal strictures, LGV is found more commonly in blacks. SexLGV is significantly more common in men than in women. Men are more likely to present with inguinal lymphadenopathy in the second stage of the disease. Women and homosexual men who engage in receptive anal intercourse are more likely to present with complications of late disease. AgePeak range is in individuals aged 15-40 years. Please click here to view the full topic text: Lymphogranuloma Venereum |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |